Immune System Basics

Part of Vaccines

How the body’s defense systems recognize and destroy pathogens — the foundation of vaccine science.

Why This Matters

Vaccines work by training the immune system. Without a basic understanding of how immunity functions, the decisions involved in vaccine development — what to use, how much, by what route, on what schedule — are arbitrary. With that understanding, they are rational.

The immune system is one of the most complex biological systems in the human body, but its core logic is elegant: recognize self from non-self, destroy non-self, and remember what you have destroyed so you can respond faster next time. Vaccines exploit this third capacity — immunological memory — to prepare the body for a pathogen it has never encountered in its dangerous natural form.

Even a simplified model of immune function is sufficient to guide practical decisions about vaccination. A practitioner who understands the difference between innate and adaptive immunity, and between cellular and humoral responses, can make sound judgments about vaccine design, dosing, and scheduling.

The Two Arms of Immunity

The immune system is divided into two interconnected branches:

Innate Immunity

Innate immunity is the body’s immediate, non-specific defense. It does not distinguish between different types of bacteria or viruses — it simply recognizes patterns common to foreign material (pathogen-associated molecular patterns, or PAMPs) and responds immediately.

Components:

• Physical barriers: Skin, mucous membranes, stomach acid — prevent entry
• Phagocytes: Neutrophils and macrophages engulf and destroy foreign material
• Inflammatory response: Redness, heat, swelling, pain at sites of infection — increases blood flow and recruits more immune cells
• Fever: Elevated body temperature inhibits pathogen replication and accelerates immune cell activity
• Complement system: Proteins in blood that punch holes in bacterial membranes
• Natural killer cells: Kill infected cells before specific immunity activates

Timing: Responds within minutes to hours.

Limitation: Non-specific. Cannot distinguish between different pathogens. Effective for common threats but overwhelmed by unfamiliar organisms.

Adaptive Immunity

Adaptive immunity is specific, learned, and remembered. It takes days to weeks to develop fully but produces targeted responses and long-lasting memory.

Key features:

• Specificity: Recognizes unique molecular patterns (antigens) on specific pathogens
• Memory: After first exposure, forms long-lived memory cells that respond faster and more powerfully on re-exposure
• Diversity: Can recognize billions of different antigens through random receptor generation
• Self-tolerance: Normally does not attack the body’s own tissues (failure = autoimmune disease)

Adaptive immunity has two arms, both relevant to vaccine function.

Humoral Immunity: The Antibody System

Humoral immunity is mediated by B cells and the antibodies they produce.

How it works:

1. A foreign antigen enters the body.
2. Antigen is taken up by antigen-presenting cells (macrophages, dendritic cells) and displayed on their surface.
3. B cells with receptors matching the antigen are selected and activated.
4. With T cell help, activated B cells multiply and differentiate into plasma cells — antibody factories.
5. Plasma cells secrete large quantities of antibodies — proteins that bind specifically to the antigen.
6. Antibodies neutralize pathogens (block function), mark them for destruction (opsonization), and activate complement.
7. After the infection clears, most plasma cells die, but a small population of memory B cells persists for decades.
8. On re-exposure, memory B cells rapidly expand and produce high levels of antibody within days.

Relevance to vaccination: Most vaccines work primarily through humoral immunity. The vaccine antigen stimulates antibody production; when the real pathogen appears, antibodies are already present or rapidly produced to neutralize it.

Measurable marker: Serum antibody titer — the concentration of specific antibodies in blood. Rising titer after vaccination confirms seroconversion (immune response). High titer correlates with protection for many diseases.

Cellular Immunity: T Cells

Cellular immunity is mediated by T lymphocytes (T cells) and is essential for:

• Killing cells infected with intracellular pathogens (viruses, Mycobacterium tuberculosis)
• Activating macrophages to destroy intracellular bacteria
• Helping B cells make better antibodies
• Regulating the immune response to prevent excessive damage

Types of T cells:

• CD4+ helper T cells: Orchestrate the immune response; provide signals that activate B cells and cytotoxic T cells
• CD8+ cytotoxic T cells: Directly kill infected cells by recognizing infected cell surface markers
• Regulatory T cells: Suppress excessive immune responses; prevent autoimmunity

Relevance to vaccination: Live attenuated vaccines stimulate strong cellular immunity because they replicate inside host cells, like natural infection. Killed vaccines stimulate weaker cellular immunity. For diseases controlled primarily by cellular immunity (tuberculosis, some viral diseases), live or subunit vaccines that stimulate T cells are more effective.

The Antigen-Antibody Interaction

Antigens are the molecular structures that the immune system recognizes. A single pathogen has many different antigens — surface proteins, polysaccharides, lipids. Different antigens vary in their ability to stimulate the immune system:

T-dependent antigens (proteins): Require T cell help for full B cell response. Produce high-quality antibodies, class switching (different antibody types), and long-lived memory. Most vaccine antigens are proteins.

T-independent antigens (polysaccharides): Can stimulate B cells without T cell help, but produce weaker, shorter-lived responses and no memory in young children (under age 2). Plain polysaccharide vaccines work poorly in infants for this reason.

Conjugate vaccines: Attach polysaccharides to protein carriers, converting T-independent responses to T-dependent ones. This is how Haemophilus influenzae type b (Hib) and meningococcal vaccines work. Requires laboratory chemistry.

Innate-Adaptive Interaction: Adjuvants Explained

Innate immune activation is necessary to trigger a full adaptive immune response. Antigens alone — particularly killed or purified ones — often fail to activate innate immunity sufficiently. Adjuvants provide the necessary innate “danger signal.”

How adjuvants work:

• Depot effect: slow antigen release from injection site, prolonging exposure
• Innate activation: stimulate toll-like receptors and other pattern recognition receptors on antigen-presenting cells
• Inflammation: trigger localized inflammation, increasing dendritic cell maturation and antigen uptake

Result: Larger, longer-lasting adaptive immune response from the same dose of antigen.

This is why alum-adsorbed killed vaccines produce better immunity than unadsorbed ones, and why live vaccines (which naturally activate innate immunity through replication) often work with a single dose while killed vaccines require multiple.

Passive vs. Active Immunity

Active immunity: The body’s own immune system responds to a challenge (natural infection or vaccination) and produces memory. Takes days to weeks to develop but lasts years.

Passive immunity: Transfer of pre-formed antibodies from one individual to another. Immediate protection but temporary — antibodies are metabolized over weeks to months.

Sources of passive immunity:

• Maternal antibodies transferred to fetus in utero and via breast milk (protects newborns for first months of life)
• Convalescent serum — blood from recovered patients, used as emergency treatment
• Animal antisera — immunized horses or other animals as antibody source (tetanus antitoxin, historically)

Implications for vaccination:

• Maternal antibodies interfere with infant vaccines — measles vaccine given before 9 months often fails because maternal antibodies neutralize vaccine virus
• Passive transfer is a treatment, not prevention — it provides immediate protection when vaccination has already occurred or when time is insufficient for active immunization

Memory: The Key to Vaccination

Immunological memory is why vaccines work long-term.

After first exposure, a small percentage of responding B and T cells differentiate into long-lived memory cells that:

• Persist for decades (sometimes lifetime) without needing ongoing antigen exposure
• Maintain lower activation threshold than naive cells — respond more quickly
• Produce higher-quality antibodies through ongoing mutation and selection (affinity maturation)

When the real pathogen appears, memory cells activate within 24-48 hours rather than the 7-14 days needed for a primary response. This often prevents disease entirely or dramatically reduces its severity.

The central goal of any vaccine is to generate this memory response — specifically against the pathogen components that are most important for protection.

Topics covered in dedicated articles: Innate Immunity, Memory Cells